Does MEPOLIZUMAB Cause Neoplasm malignant? 160 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 160 reports of Neoplasm malignant have been filed in association with MEPOLIZUMAB (Nucala). This represents 0.4% of all adverse event reports for MEPOLIZUMAB.
160
Reports of Neoplasm malignant with MEPOLIZUMAB
0.4%
of all MEPOLIZUMAB reports
14
Deaths
45
Hospitalizations
How Dangerous Is Neoplasm malignant From MEPOLIZUMAB?
Of the 160 reports, 14 (8.8%) resulted in death, 45 (28.1%) required hospitalization, and 6 (3.8%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEPOLIZUMAB. However, 160 reports have been filed with the FAERS database.
What Other Side Effects Does MEPOLIZUMAB Cause?
Asthma (11,033)
Dyspnoea (9,192)
Wheezing (6,093)
Product dose omission issue (5,873)
Cough (4,577)
Pneumonia (4,107)
Therapeutic product effect incomplete (4,106)
Drug ineffective (3,880)
Loss of personal independence in daily activities (3,566)
Fatigue (2,656)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which MEPOLIZUMAB Alternatives Have Lower Neoplasm malignant Risk?
MEPOLIZUMAB vs MEPROBAMATE
MEPOLIZUMAB vs MERCAPTOPURINE
MEPOLIZUMAB vs MEROPENEM
MEPOLIZUMAB vs MEROPENEM ANHYDROUS
MEPOLIZUMAB vs MESALAMINE